A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

In the study, patients who had recovered from an COVID infection were injected with a small amount of the 89Zr-labeled radiotracer before undergoing a uExplorer PET/CT scan.

This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.

Experts recently detailed their efforts to garner more student interest in the field—efforts that were successful, according to a survey responses from students who completed a short nuc med seminar.

Better risk stratification can improve clinical decision making and better outcomes, experts involved in the study explained in EJR.

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

"Clinical study protocols may involve more than one PET [amyloid-beta] scan per patient,” the CMS announcement said.